ATE73328T1 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
ATE73328T1
ATE73328T1 AT88304008T AT88304008T ATE73328T1 AT E73328 T1 ATE73328 T1 AT E73328T1 AT 88304008 T AT88304008 T AT 88304008T AT 88304008 T AT88304008 T AT 88304008T AT E73328 T1 ATE73328 T1 AT E73328T1
Authority
AT
Austria
Prior art keywords
antacid
cimetidine
pharmaceutical compositions
water
compositions
Prior art date
Application number
AT88304008T
Other languages
English (en)
Inventor
Gordon France
Graham Stanley Leonard
Kevin Edward Pearmain
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878710965A external-priority patent/GB8710965D0/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of ATE73328T1 publication Critical patent/ATE73328T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88304008T 1987-05-08 1988-05-04 Pharmazeutische zusammensetzungen. ATE73328T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878710965A GB8710965D0 (en) 1987-05-08 1987-05-08 Pharmaceutical compositions
EP88304008A EP0294933B1 (de) 1987-05-08 1988-05-04 Pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE73328T1 true ATE73328T1 (de) 1992-03-15

Family

ID=26116143

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88304008T ATE73328T1 (de) 1987-05-08 1988-05-04 Pharmazeutische zusammensetzungen.

Country Status (2)

Country Link
EP (1) EP0294933B1 (de)
AT (1) ATE73328T1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000102A1 (en) 1990-06-22 1992-01-09 Beecham Group Plc Novel treatment
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DE69207656T2 (de) * 1991-01-30 1996-10-17 The Wellcome Foundation Ltd., London Wasserlösliche tabletten
US5272191A (en) * 1991-08-21 1993-12-21 Fmc Corporation Cold water soluble films and film forming compositions
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
DE4333190C2 (de) * 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung
US5593696A (en) * 1994-11-21 1997-01-14 Mcneil-Ppc, Inc. Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
SE9600071D0 (sv) † 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
WO1998014198A1 (en) * 1996-10-04 1998-04-09 Merck & Co., Inc. Methods and compositions for preventing and treating heartburn
US5989588A (en) * 1996-10-04 1999-11-23 Merck & Co., Inc. Methods and compositions for preventing and treating heartburn
JP3001440B2 (ja) * 1996-11-25 2000-01-24 日本電気通信システム株式会社 仮想ｌａｎ方式
EP1295926A1 (de) 2001-09-19 2003-03-26 ExxonMobil Chemical Patents Inc. Komponente für Klebstoffe und Verfahren zur deren Herstellung
WO2017091166A1 (en) 2015-11-26 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. Stable pharmaceutical compositions and process for their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3501571A (en) * 1965-12-06 1970-03-17 Smithkline Corp Novel silicone compositions and method of preparing same
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine

Also Published As

Publication number Publication date
EP0294933B1 (de) 1992-03-11
EP0294933A3 (en) 1989-02-08
EP0294933A2 (de) 1988-12-14

Similar Documents

Publication Publication Date Title
WO1988008704A3 (en) Pharmaceutical compositions
ATE73328T1 (de) Pharmazeutische zusammensetzungen.
DE69001730D1 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
IL95691A0 (en) Thienylcarboxylates of amino alcohols,their preparation and pharmaceutical compositions containing them
CA2024291A1 (en) Dosage device and preparation and use thereof
EP1287822A3 (de) Mesalazine enthaltende pharmazeutische Zusammensetzungen mit gesteuerter Freisetzung
ATE134134T1 (de) Feste arzneizubereitungen zur oralen verabreichung mit verlängerter magenverweilzeit
DE3887513D1 (de) Chemische formulierungen.
DE69733476D1 (de) Im munde schnellzerfallende tablette
DK415689D0 (da) Farmaceutiske midler
FI864605A0 (fi) Terapeutiska sammansaettningar.
ATE203411T1 (de) Lagerstabile wässrige pharmazeutische zubereitungen von g-csf
DE68902531D1 (de) Dispergierbare zubereitung.
SE8204581L (sv) Farmaceutiska excipienter
HU893273D0 (en) Pesticide preparation in the form of tablets
NO890187L (no) 2-(3,4-dihydroksyfenyl)etylaminer, deres fremstilling og anvendelse som farmasoeytika.
DK0427124T3 (da) Antacidatabletter
ATE70445T1 (de) Pharmazeutische praeparate.
FI922698A0 (fi) Foerbaettrade acetazolamidpreparat.
EP0261524A3 (de) Arzneimittelzubereitungen
EP0209843A3 (de) Benzylpiperazin-Verbindung, deren Herstellung, pharmazeutische Zusammensetzung und Verwendung
TR23253A (tr) Zorunlu olarak sodyum suelfat meydana gelmeden parafin-sulfoksidasyon-reaksiyon karisimlarindan alkali suelfat bakimindan fakir parafin suelfonot'larinin ve suelfuerik asidin izde edilmesine mahsus usul
IT8921722A0 (it) Composizioni farmaceutiche stabili a base di calcitonina.
IT8922398A0 (it) Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time